generic drugs that "bow their heads and be human" in other countries are launched in India, because India has implemented "compulsory patent licensing" for drugs on the grounds of low national income. Their behavior began with the authorization of the government.
Recently, Dying to Survive, a domestically produced film with an explosive reputation, not only reaped the tears of countless audiences, but also made the word "generic drug" a hot topic. What is a generic drug? Simply put, it is a "real medicine" that does not have a patent. The original drug is hard to buy at a sky-high price, and the generic drug with the same efficacy at a low price naturally has a great market. When it comes to generic drugs, we have to talk about India, the "world pharmacy" that dominates the world by it.
In India, the cost of producing generic drugs is more than 6% lower than that of the United States, which gives India an absolute advantage in the export of generic drugs. A large number of Indian generic drugs are exported to the United States, which has also brought a big impact on the generic drug industry in the United States. But in recent years, Indian generic drugs have suffered a sudden change in the US market. The most direct reason is that the FDA has accelerated the approval of generic drugs, and Indian generic pharmaceutical companies have more competitors.
why can generic drugs that "bow their heads" in other countries "open up" in India? Here is a top-down "high-priced drug counter-system". India has always adhered to the "drug compulsory licensing system", that is to say, Indian pharmaceutical companies can copy expensive drugs from western countries with the authorization and permission of the Indian government. Before Modi's government, India had launched the "Jan Aushadhi Government Plan" to encourage pharmacies to sell commonly used life-saving drugs. After the Modi government came to power in 214, it continued to promote this plan, allowing 3, pharmacies to sell "generic drugs".